サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1279831

セントラルラボの世界市場規模調査＆予測、サービス別、エンドユーザー別、地域別分析、2022-2029年

Global Central Lab Market Size study & Forecast, by Services, by End User, and Regional Analysis, 2022-2029

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
セントラルラボの世界市場規模調査＆予測、サービス別、エンドユーザー別、地域別分析、2022-2029年
出版日: 2023年05月15日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

セントラルラボは、すべての臨床現場からサンプルが送られてくる検査室です。

サンプルは臨床現場から集められ、それがセントラルラボに送られ、標準化された方法ですべてのラボテストを実行します。

世界のセントラルラボ市場の成長は、主にこれから出てくる市場によってもたらされます。満たされていないヘルスケア需要が多く、これがヘルスケア施設やインフラの改善につながります。慢性疾患の増加は、臨床試験の増加につながり、それがサンプルの増加につながるため、セントラルラボ市場の成長につながるでしょう。世界保健機関（WHO）によると、低所得国の臨床試験数は高所得国の約100分の1です。さらに、革新的な医薬品は、基本的に様々な治療方法を提供する疾患に対する需要が高まっています。このような革新的な医薬品は、前臨床試験を経て承認される必要があり、これがセントラルラボの促進要因となります。米国議会予算局が発表した報告書によると、製薬業界が研究開発に費やす総額は、2019年に830億米ドルに上ります。しかし、結果の質、正確性、迅速性がセントラル・ラボの抑制要因となっています。ターンアラウンドタイムは、ラボのパフォーマンスを示す主要な指標の1つです。米国国立衛生研究所（NIH）の報告によると、許容できるターンアラウンドタイムは、一般的なラボの検査で90％の完了時間<60％です。

COVID-19のパンデミックは、ワクチン開発により焦点が当てられ、COVID-19治療のための多くの調査が行われているため、セントラルラボに成長機会をもたらしています。採取されたサンプルとそれに関連する物流は迅速であるべきで、サンプルは慎重に扱われるべきであり、これはセントラルラボにとって、より正確な結果を得るためにサンプルの安定性を維持する機会を創出することになります。Hindustan Timesの報告によると、インドは過去5～6ヶ月で1000万以上のサンプルでCOVID-19の検査を行い、この報告は2020年7月に発表されています。どの国でも高齢者は多くの病気に直面しており、そのため治療用の費用対効果の高い製品への需要が高まっており、これが業界の研究開発への集中につながります。全米高齢化評議会によると、65歳以上の成人の80％が少なくとも1つの慢性疾患に直面しており、そのうちの68％が2つ以上の疾患を抱えています。その結果、臨床試験の機会が増え、セントラルラボサービスに対する需要が高まることが予想されます。

世界のセントラルラボ市場の調査で考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他ラテンアメリカを含みます。北米は、米国での臨床試験の増加や医薬品の研究開発が盛んであること、慢性疾患の増加がセントラルラボの需要増につながったことなどの理由から、売上高で市場を独占しています。アジア太平洋地域は、セントラルラボサービスの増加、政府の積極的な支援、研究開発の増加などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。BioSpectrum Asia社の統計によると、非伝染性疾患が急速に増加しており、東南アジアでは死因の約55％が非伝染性疾患によるものです。これらの疾患の増加は、アジア太平洋地域におけるセントラルラボの需要を増加させています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推計・予測、2019年～2029年
    • セントラルラボ市場、地域別、2019年～2029年
    • セントラルラボ市場：サービス別、2019年～2029年
    • セントラルラボ市場、エンドユーザー別、2019年～2029年
  • 主な動向
  • 予測手法
  • 調査の前提条件

第2章 セントラルラボの世界市場の定義と範囲

  • 本調査の目的
  • 市場の定義とスコープ
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 セントラルラボの世界市場力学

  • セントラルラボの市場インパクト分析（2019年～2029年）
    • 市場促進要因
      • 慢性疾患の増加
      • 革新的な医薬品に対する需要の増加
    • 市場の課題
      • セントラルラボのターンアラウンド
    • 市場機会
      • COVID-19症例の増加
      • 世界の高齢者の多発性疾患

第4章 世界のセントラルラボ市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ（2019年～2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップクラスの投資機会
  • 主要成功戦略

第5章 リスクアセスメント：COVID-19のインパクト

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 セントラルラボの世界市場、サービス別

  • 市場スナップショット
  • セントラルラボの世界市場、サービス別、実績-ポテンシャル分析
  • セントラルラボの世界市場、サービス別推定・予測2019-2029
  • セントラルラボ市場、サブセグメント別分析
    • バイオマーカーサービス
    • 検体管理・保管
    • 解剖学的病理学と組織学
    • 遺伝子関連サービス
    • その他

第7章 セントラルラボの世界市場：エンドユーザー別

  • マーケットスナップショット
  • セントラルラボの世界市場：エンドユーザー別、実績-ポテンシャル分析
  • セントラルラボの世界市場、エンドユーザー別推定・予測2019-2029
  • セントラルラボ市場、サブセグメント別分析
    • バイオテクノロジー企業
    • 製薬会社
    • その他

第8章 セントラルラボの世界市場：地域別分析

  • セントラルラボ市場、地域別市場スナップショット
  • 北米
    • 米国
      • サービス別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019年～2029年
    • カナダ
  • 欧州セントラルラボ市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • アジア太平洋地域のセントラルラボ市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのセントラルラボ市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Cirion Biopharma Research Inc.
      • 主要情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • ACM Global Laboratories
    • Eurofins Scientific
    • Lambda Therapeutics Research Ltd.
    • A.P. Moller Holdings A/S
    • Frontage Laboratories Inc.
    • Interlab Central Lab Services
    • Medicover Integrated Clinical Services
    • Rochester Regional Health
    • Laboratory Corporation of America Holdings

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Central Lab Market, report scope
  • TABLE 2. Global Central Lab Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Central Lab Market estimates & forecasts by Service 2019-2029 (USD Billion)
  • TABLE 4. Global Central Lab Market estimates & forecasts by End User 2019-2029 (USD Billion)
  • TABLE 5. Global Central Lab Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Central Lab Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Central Lab Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Central Lab Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Central Lab Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Central Lab Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Central Lab Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Central Lab Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Central Lab Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Central Lab Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Central Lab Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Central Lab Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Central Lab Market
  • TABLE 70. List of primary sources, used in the study of global Central Lab Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Central Lab Market, research methodology
  • FIG 2. Global Central Lab Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Central Lab Market, key trends 2021
  • FIG 5. Global Central Lab Market, growth prospects 2022-2029
  • FIG 6. Global Central Lab Market, porters 5 force model
  • FIG 7. Global Central Lab Market, pest analysis
  • FIG 8. Global Central Lab Market, value chain analysis
  • FIG 9. Global Central Lab Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Central Lab Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Central Lab Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Central Lab Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Central Lab Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Central Lab Market, regional snapshot 2019 & 2029
  • FIG 15. North America Central Lab Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Central Lab Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Central Lab Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Central Lab Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Central Lab Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Central Lab Market is valued at approximately USD xx billion in 2021 and is anticipated to grow with a healthy growth rate of more than x% over the forecast period 2022-2029.

Central Lab is a laboratory where the samples were sent from all the clinical sites. Samples are collected from clinical sites and then it was sent to the central laboratory and then they run all the laboratory tests by standardized methods.

The growth of the Global Central Lab Market is mainly driven by markets that are coming out. There are a lot of unmet healthcare demands, and this will lead to improvements in healthcare facilities and infrastructure. An increase in chronic diseases will lead to an increase in clinical trials which will lead to an increase in samples and thus will lead to growth in Central Lab Market. As per World Health Organization, the number of trials in low-income countries were almost 100 times less than in high-income countries. Moreover, the demand for innovative drugs is growing for diseases which basically gives different ways for treatment. For this kind of innovative product, they need to enter preclinical stages for approval which will become a growth driver for Central Labs. As per the reports published by Congressional Budget Office, the total amount spent by the pharmaceutical industry on R&D is USD 83 billion in 2019. However, the quality of results, accuracy and rapidity are the restraining factors for central labs. The turnaround time is one of the major indicators of the performance of the laboratory. As per reports by the National Institute of Health (NIH), the acceptable turnaround time is 90% completion time<60% for general lab tests.

The COVID-19 pandemic has created growth opportunities for central labs because there is more focus on vaccine development and there are a lot of investigations going on for COVID-19 treatment. The samples that have been collected and handled and the logistics related to that should be fast and samples should be handled carefully, this will create an opportunity for central labs to maintain sample stability to get more accurate results. As per the report by Hindustan Times, India has tested more than 10 million samples for COVID-19 in the last 5-6 months and this report has been published in July 2020. Senior citizens in every country are facing a lot of multiple diseases which thus increases the demand for cost-effective products for their treatment and this will lead to the industry's focus on R&D. As per the National Council of Aging, adults who are 65 and above of age so 80% of them are facing at least one chronic disease and among them, 68% have two or more. Now, as a result, it will create more and more opportunities for clinical trials and thus it will lead to greater demand for central lab services.

The key regions considered for the Global Central Lab Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the reasons such as the increase in clinical trials in the USA and there has been lot of research and development in drugs and the growing chronic diseases also led to an increase in demand for central labs. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to the factors such as the growing central lab services, there is also positive government support and the increase in research and development also led to increasing in demand for central labs. As per the statistics by BioSpectrum Asia, there has been a rapid increase in non-communicable diseases and around 55% of deaths are due to non-communicable diseases in Southeast Asia. The increase in these diseases increases the demand for central labs in the Asia Pacific.

Major market players included in this report are:

  • Cirion Biopharma Research Inc.
  • ACM Global Laboratories
  • Eurofins Scientific
  • Lambda Therapeutics Research Ltd.
  • A.P. Moller Holding A/S
  • Frontage Laboratories Inc.
  • Interlab Central Lab Services
  • Medicover Integrated Clinical Services
  • Rochester Regional Health
  • Laboratory Corporation of America Holdings

Recent Developments in the Market:

  • In June 2021, a wholly owned subsidiary of IQVIA, Q2 Solutions has declared the extension of their clinical laboratory services and extension of their operational functions at Alba Campus in Livingston, Scotland. This will support pharma and biopharma clients globally and will drive finer patient outcomes.
  • In September 2021, a top global clinical research organization, Emmes, combined with its CRO Orphan Reach, declared that they have signed a new agreement for 5 years to increase their relationship with Eurofins Central Laboratory.
  • In June 2022, Labcorp Inc. which is a top global life sciences company declared that they will be extending their drug development operations and central laboratory in Japan through the extension of the CB trial Laboratory which is the Central Lab that is co-managed by a leading Japanese service provider of clinical labs testing services, known BML and Labcorp Drug Development.

Global Central Lab Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Services, End User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Services:

  • Biomarker Services
  • Specimen Management and Storage
  • Anatomic Pathology and Histology
  • Genetic Services
  • Others

By End User:

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Central Lab Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Central Lab Market, by Service, 2019-2029 (USD Billion)
    • 1.2.3. Central Lab Market, by End User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Central Lab Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Central Lab Market Dynamics

  • 3.1. Central Lab Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in Chronic Diseases
      • 3.1.1.2. Increase in demand for innovative drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Turnaround of central labs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in Covid-19 cases
      • 3.1.3.2. Multiple diseases of senior citizens globally

Chapter 4. Global Central Lab Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Central Lab Market, by Service

  • 6.1. Market Snapshot
  • 6.2. Global Central Lab Market by Service, Performance - Potential Analysis
  • 6.3. Global Central Lab Market Estimates & Forecasts by Service 2019-2029 (USD Billion)
  • 6.4. Central Lab Market, Sub Segment Analysis
    • 6.4.1. Biomarker Services
    • 6.4.2. Specimen Management and Storage
    • 6.4.3. Anatomic Pathology and Histology
    • 6.4.4. Genetic Services
    • 6.4.5. Others

Chapter 7. Global Central Lab Market, by End User

  • 7.1. Market Snapshot
  • 7.2. Global Central Lab Market by End User, Performance - Potential Analysis
  • 7.3. Global Central Lab Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
  • 7.4. Central Lab Market, Sub Segment Analysis
    • 7.4.1. Biotechnology Companies
    • 7.4.2. Pharmaceutical Companies
    • 7.4.3. Others

Chapter 8. Global Central Lab Market, Regional Analysis

  • 8.1. Central Lab Market, Regional Market Snapshot
  • 8.2. North America Central Lab Market
    • 8.2.1. U.S. Central Lab Market
      • 8.2.1.1. Service breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Central Lab Market
  • 8.3. Europe Central Lab Market Snapshot
    • 8.3.1. U.K. Central Lab Market
    • 8.3.2. Germany Central Lab Market
    • 8.3.3. France Central Lab Market
    • 8.3.4. Spain Central Lab Market
    • 8.3.5. Italy Central Lab Market
    • 8.3.6. Rest of Europe Central Lab Market
  • 8.4. Asia-Pacific Central Lab Market Snapshot
    • 8.4.1. China Central Lab Market
    • 8.4.2. India Central Lab Market
    • 8.4.3. Japan Central Lab Market
    • 8.4.4. Australia Central Lab Market
    • 8.4.5. South Korea Central Lab Market
    • 8.4.6. Rest of Asia Pacific Central Lab Market
  • 8.5. Latin America Central Lab Market Snapshot
    • 8.5.1. Brazil Central Lab Market
    • 8.5.2. Mexico Central Lab Market
  • 8.6. Rest of The World Central Lab Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Cirion Biopharma Research Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. ACM Global Laboratories
    • 9.2.3. Eurofins Scientific
    • 9.2.4. Lambda Therapeutics Research Ltd.
    • 9.2.5. A.P. Moller Holdings A/S
    • 9.2.6. Frontage Laboratories Inc.
    • 9.2.7. Interlab Central Lab Services
    • 9.2.8. Medicover Integrated Clinical Services
    • 9.2.9. Rochester Regional Health
    • 9.2.10. Laboratory Corporation of America Holdings

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption